Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Bowden

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Annals of the New York Academy of Sciences|April 17, 2007
Microsensor arrays for saliva diagnosticsDavid R Walt, Timothy M Blicharz, Ryan B Hayman, et al.
Iscience|November 24, 2018
Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune InfiltrationZeya Wang, Shaolong Cao, Jeffrey S Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2017
Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicingTeng Fei, Yiwen Chen, Tengfei Xiao, et al.
Frontiers in Oncology|September 14, 2017
Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue CancerGuilherme Rabinowits, Michaela Bowden, Ludmila M Flores, et al.
Cancer & Metabolism|December 17, 2016
The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control studyRachel S Kelly, Jennifer A Sinnott, Jennifer R Rider, et al.
Nature Genetics|October 13, 2015
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisMark M Pomerantz, Fugen Li, David Y Takeda, et al.
The Lancet. Oncology|November 10, 2016
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trialJoel W Neal, Suzanne E Dahlberg, Heather A Wakelee, et al.
Cancer Research|December 1, 2016
Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6Atish D Choudhury, Anna C Schinzel, Maura B Cotter, et al.
Cancer Cell|August 14, 2014
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressorGang Lu, Qing Zhang, Ying Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Embryonic transcription factor SOX9 drives breast cancer endocrine resistanceRinath Jeselsohn, MacIntosh Cornwell, Matthew Pun, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Annals of the New York Academy of Sciences|April 17, 2007
Microsensor arrays for saliva diagnosticsDavid R Walt, Timothy M Blicharz, Ryan B Hayman, et al.
Iscience|November 24, 2018
Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune InfiltrationZeya Wang, Shaolong Cao, Jeffrey S Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2017
Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicingTeng Fei, Yiwen Chen, Tengfei Xiao, et al.
Frontiers in Oncology|September 14, 2017
Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue CancerGuilherme Rabinowits, Michaela Bowden, Ludmila M Flores, et al.
Cancer & Metabolism|December 17, 2016
The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control studyRachel S Kelly, Jennifer A Sinnott, Jennifer R Rider, et al.
Nature Genetics|October 13, 2015
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisMark M Pomerantz, Fugen Li, David Y Takeda, et al.
The Lancet. Oncology|November 10, 2016
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trialJoel W Neal, Suzanne E Dahlberg, Heather A Wakelee, et al.
Cancer Research|December 1, 2016
Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6Atish D Choudhury, Anna C Schinzel, Maura B Cotter, et al.
Cancer Cell|August 14, 2014
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressorGang Lu, Qing Zhang, Ying Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Embryonic transcription factor SOX9 drives breast cancer endocrine resistanceRinath Jeselsohn, MacIntosh Cornwell, Matthew Pun, et al.
Pageof 6